Back to Search Start Over

Self-Reinforced Bimetallic Mito-Jammer for Ca 2+ Overload-Mediated Cascade Mitochondrial Damage for Cancer Cuproptosis Sensitization.

Authors :
Du C
Guo X
Qiu X
Jiang W
Wang X
An H
Wang J
Luo Y
Du Q
Wang R
Cheng C
Guo Y
Teng H
Ran H
Wang Z
Li P
Zhou Z
Ren J
Source :
Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2024 Apr; Vol. 11 (15), pp. e2306031. Date of Electronic Publication: 2024 Feb 11.
Publication Year :
2024

Abstract

Overproduction of reactive oxygen species (ROS), metal ion accumulation, and tricarboxylic acid cycle collapse are crucial factors in mitochondria-mediated cell death. However, the highly adaptive nature and damage-repair capabilities of malignant tumors strongly limit the efficacy of treatments based on a single treatment mode. To address this challenge, a self-reinforced bimetallic Mito-Jammer is developed by incorporating doxorubicin (DOX) and calcium peroxide (CaO <subscript>2</subscript> ) into hyaluronic acid (HA) -modified metal-organic frameworks (MOF). After cellular, Mito-Jammer dissociates into CaO <subscript>2</subscript> and Cu <superscript>2+</superscript> in the tumor microenvironment. The exposed CaO <subscript>2</subscript> further yields hydrogen peroxide (H <subscript>2</subscript> O <subscript>2</subscript> ) and Ca <superscript>2+</superscript> in a weakly acidic environment to strengthen the Cu <superscript>2+</superscript> -based Fenton-like reaction. Furthermore, the combination of chemodynamic therapy and Ca <superscript>2+</superscript> overload exacerbates ROS storms and mitochondrial damage, resulting in the downregulation of intracellular adenosine triphosphate (ATP) levels and blocking of Cu-ATPase to sensitize cuproptosis. This multilevel interaction strategy also activates robust immunogenic cell death and suppresses tumor metastasis simultaneously. This study presents a multivariate model for revolutionizing mitochondria damage, relying on the continuous retention of bimetallic ions to boost cuproptosis/immunotherapy in cancer.<br /> (© 2024 The Authors. Advanced Science published by Wiley‐VCH GmbH.)

Details

Language :
English
ISSN :
2198-3844
Volume :
11
Issue :
15
Database :
MEDLINE
Journal :
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Publication Type :
Academic Journal
Accession number :
38342617
Full Text :
https://doi.org/10.1002/advs.202306031